CAS 82-92-8|Cyclizine

Introduction:Basic information about CAS 82-92-8|Cyclizine, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Common NameCyclizine
CAS Number82-92-8Molecular Weight266.38100
Density/Boiling Point/
Molecular FormulaC18H22N2Melting Point/
MSDS/Flash Point/

Names

Namecyclizine
SynonymMore Synonyms

Chemical & Physical Properties

Molecular FormulaC18H22N2
Molecular Weight266.38100
Exact Mass266.17800
PSA6.48000
LogP2.89920
InChIKeyUVKZSORBKUEBAZ-UHFFFAOYSA-N
SMILESCN1CCN(C(c2ccccc2)c2ccccc2)CC1

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
TL6475000
CHEMICAL NAME :
Piperazine, 1-(diphenylmethyl)-4-methyl-
CAS REGISTRY NUMBER :
82-92-8
BEILSTEIN REFERENCE NO. :
0230441
LAST UPDATED :
199612
DATA ITEMS CITED :
5
MOLECULAR FORMULA :
C18-H22-N2
MOLECULAR WEIGHT :
266.42
WISWESSER LINE NOTATION :
T6N DNTJ AYR&R& D1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
126 mg/kg/6W-I
TOXIC EFFECTS :
Blood - agranulocytosis
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year: 292,174,1986
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
147 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,218,1972 ** REPRODUCTIVE DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
450 mg/kg
SEX/DURATION :
female 10-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
BCFAAI Bollettino Chimico Farmaceutico. (Societa Editoriale Farmaceutica, Via Ausonio 12, 20123 Milan, Italy) V.33- 1894- Volume(issue)/page/year: 109,323,1970
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
450 mg/kg
SEX/DURATION :
female 10-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - homeostasis Reproductive - Effects on Newborn - stillbirth
REFERENCE :
BCFAAI Bollettino Chimico Farmaceutico. (Societa Editoriale Farmaceutica, Via Ausonio 12, 20123 Milan, Italy) V.33- 1894- Volume(issue)/page/year: 109,323,1970 *** REVIEWS *** TOXICOLOGY REVIEW ADVPA3 Advances in Pharmacology. (New York, NY) V.1-6, 1962-68. For publisher information, see AVPCAQ. Volume(issue)/page/year: 4,263,1966

Safety Information

Hazard CodesT+
HS Code2933599090

Customs

HS Code2933599090
Summary2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Synonyms

Ciclizina
Marzine
N-benzhydryl-N'-methylpiperazine
Valoid
Bw 47-83
Marazine
1-Benzhydryl-4-methyl-piperazin
Emoquil
Nautazine
Marezine
Wellcome
CYCLIZINE HCL
1-diphenylmethyl-4-methylpiperazine
1-benzhydryl-4-methyl-piperazine
CAS 7784-16-9|sodium,tetrachloroalumanuide
CAS 861411-30-5|(Z)-2-(Benzo[d]thiazol-2(3H)-ylidene)-2-(2-chloropyrimidin-4-yl)acetonitrile
Recommended......
TOP